ENTRY       D11762                      Drug
NAME        Lucitanib (USAN/INN)
FORMULA     C26H25N3O4
EXACT_MASS  443.1845
MOL_WEIGHT  443.4944
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
COMMENT     Treatment of solid tumors
TARGET      FGFR1 (CD331) [HSA:2260] [KO:K04362]
            FGFR2 (CD332) [HSA:2263] [KO:K05093]
            VEGFR1 (FLT1) [HSA:2321] [KO:K05096]
            VEGFR2 (KDR) [HSA:3791] [KO:K05098]
            VEGFR3 (FLT4) [HSA:2324] [KO:K05097]
  PATHWAY   hsa04010(2260+2263+2321+2324+3791)  MAPK signaling pathway
            hsa04151(2260+2263+2321+2324+3791)  PI3K-Akt signaling pathway
            hsa05200(2260+2263+2324)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               FGFR family
                FGFR1 (CD331)
                 D11762  Lucitanib (USAN/INN)
                FGFR2 (CD332)
                 D11762  Lucitanib (USAN/INN)
               VEGFR family
                VEGFR1 (FLT1)
                 D11762  Lucitanib (USAN/INN)
                VEGFR2 (KDR)
                 D11762  Lucitanib (USAN/INN)
                VEGFR3 (FLT4)
                 D11762  Lucitanib (USAN/INN)
DBLINKS     CAS: 1058137-23-7
            PubChem: 405226628
            PDB-CCD: 3ZC
ATOM        33
            1   C8x C    21.2100  -19.6000
            2   C8x C    21.2100  -18.2000
            3   C8x C    20.0200  -17.5000
            4   C8y C    18.7600  -18.2000
            5   C8y C    18.7600  -19.6000
            6   C8y C    20.0200  -20.3000
            7   C8x C    17.5700  -17.5000
            8   C8y C    16.3800  -18.2000
            9   C8x C    16.3800  -19.6000
            10  C8x C    17.5700  -20.3000
            11  C5a C    20.0200  -21.7000
            12  N1b N    21.2100  -22.4000
            13  C1a C    22.4000  -21.7000
            14  O5a O    18.8300  -22.4000
            15  O2a O    15.1900  -17.5000
            16  C8y C    15.1900  -16.1000
            17  C8x C    16.3800  -15.4000
            18  C8x C    16.3800  -14.0000
            19  N5x N    15.1900  -13.3000
            20  C8y C    13.9300  -14.0000
            21  C8y C    13.9300  -15.4000
            22  C8x C    12.7400  -13.3000
            23  C8y C    11.5500  -14.0000
            24  C8y C    11.5500  -15.4000
            25  C8x C    12.7400  -16.1000
            26  O2a O    10.3600  -13.3000
            27  C1b C     9.1700  -14.0000
            28  C1z C     7.9800  -13.3000
            29  O2a O    10.3600  -16.1000
            30  C1a C     9.1700  -15.4000
            31  N1a N     6.7900  -14.0000
            32  C1x C     8.6800  -12.1100
            33  C1x C     7.2800  -12.1100
BOND        37
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    6  11 1
            13   11  12 1
            14   12  13 1
            15   11  14 2
            16    8  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   16  21 1
            24   20  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   21  25 1
            29   23  26 1
            30   26  27 1
            31   27  28 1
            32   24  29 1
            33   29  30 1
            34   28  31 1
            35   32  33 1
            36   33  28 1
            37   28  32 1
///
